1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Providers in the Czech Republic

Healthcare Providers in the Czech Republic

  • July 2016
  • -
  • MarketLine
  • -
  • 30 pages

Summary
Healthcare Providers in the Czech Republic industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the healthcare providers market in the Czech Republic

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the healthcare providers market in the Czech Republic

Leading company profiles reveal details of key healthcare providers market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Czech Republic healthcare providers market with five year forecasts

Synopsis
Essential resource for top-line data and analysis covering the Czech Republic healthcare providers market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
What was the size of the Czech Republic healthcare providers market by value in 2015?

What will be the size of the Czech Republic healthcare providers market in 2020?

What factors are affecting the strength of competition in the Czech Republic healthcare providers market?

How has the market performed over the last five years?

What are the main segments that make up the Czech Republic's healthcare providers market?

Key Highlights
The healthcare providers sector is valued as total expenditure on healthcare in each country. This includes final consumption spending on healthcare goods and services.

The Czech healthcare providers sector had total revenues of $12.2bn in 2015, representing a compound annual growth rate (CAGR) of 1.2% between 2011 and 2015.

The outpatient care segment was the sector's most lucrative in 2015, with total revenues of $3.8bn, equivalent to 31.3% of the sector's overall value.

Government spending on healthcare has consistently grown in recent years, and in 2015 it accounted for nearly 85% of the total sector.

Table Of Contents

Healthcare Providers in the Czech Republic
Table of Contents
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Affidea
AGEL a.s.
MediClinic a.s.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

List of Tables
Table 1: Czech Republic healthcare providers sector value: $ billion, 2011-15
Table 2: Czech Republic healthcare providers sector category segmentation: $ billion, 2015
Table 3: Czech Republic healthcare providers sector geography segmentation: $ billion, 2015
Table 4: Czech Republic healthcare providers sector distribution: % share, by value, 2015
Table 5: Czech Republic healthcare providers sector value forecast: $ billion, 2015-20
Table 6: Affidea: key facts
Table 7: AGEL a.s.: key facts
Table 8: MediClinic a.s.: key facts
Table 9: Czech Republic size of population (million), 2011-15
Table 10: Czech Republic gdp (constant 2005 prices, $ billion), 2011-15
Table 11: Czech Republic gdp (current prices, $ billion), 2011-15
Table 12: Czech Republic inflation, 2011-15
Table 13: Czech Republic consumer price index (absolute), 2011-15
Table 14: Czech Republic exchange rate, 2011-15

List of Figures
Figure 1: Czech Republic healthcare providers sector value: $ billion, 2011-15
Figure 2: Czech Republic healthcare providers sector category segmentation: % share, by value, 2015
Figure 3: Czech Republic healthcare providers sector geography segmentation: % share, by value, 2015
Figure 4: Czech Republic healthcare providers sector distribution: % share, by value, 2015
Figure 5: Czech Republic healthcare providers sector value forecast: $ billion, 2015-20
Figure 6: Forces driving competition in the healthcare providers sector in the Czech Republic, 2015
Figure 7: Drivers of buyer power in the healthcare providers sector in the Czech Republic, 2015
Figure 8: Drivers of supplier power in the healthcare providers sector in the Czech Republic, 2015
Figure 9: Factors influencing the likelihood of new entrants in the healthcare providers sector in the Czech Republic, 2015
Figure 10: Factors influencing the threat of substitutes in the healthcare providers sector in the Czech Republic, 2015
Figure 11: Drivers of degree of rivalry in the healthcare providers sector in the Czech Republic, 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary Hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections ...

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 Summary Diabetic Foot Ulcer (DFU) and Diabetic Foot Infection (DFI) market is set to triple in value from $292.1 Million ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.